CFO: Calibration-Free Odds Bayesian Designs for Dose Finding in Clinical Trials.

JCO Clin Cancer Inform · 2025 · PMC11797228 · PMID 39889256

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This work is highly significant as it integrates all existing CFO-type designs to facilitate novel trial designs with enhanced performance.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.